977 Phase I/II trial evaluating blockade of tumour blood supply and tumour cell proliferation with combined bevacizumab and erlotinib HCl as targeted cancer therapy in patients with recurrent non-small cell lung cancer
Open Access
- 30 September 2003
- journal article
- abstracts
- Published by Elsevier in European Journal of Cancer Supplements
- Vol. 1 (5) , S293
- https://doi.org/10.1016/s1359-6349(03)91004-4
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: